» Articles » PMID: 807160

Purification and Properties of Clostridium Botulinum Type F Toxin

Overview
Journal Appl Microbiol
Specialty Microbiology
Date 1975 May 1
PMID 807160
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Clostridium botulinum type F toxin of proteolytic Langeland strain was purified. Toxin in whole cultures was precipitated with (NH4)2SO4. Extract of the precipitate was successively chromatographed on diethylaminoethyl-cellulose at pH 6,0, O-(carboxymethyl) cellulose at pH 4.9, and finally diethylaminoethyl-cellulose at pH 8.1. The procedure recovered 14 percent of the toxin assayed in the starting culture. The toxin was homogeneous by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, double gel diffusion serology, and isoelectric focusing. Purified toxin had a molecular weight of 150,000 by gel filtration and 155,000 by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Specific toxicity was 9.6 X 10-6 mean lethal doses per absorbancy (278 nm) unit. Sub-units of 105,000 and 56,000 molecular weight are found when purified toxin is treated with a disulfide reducing agent and electrophoresed on sodium dodecyl sulfate-polyacrylamide gels. Reciprocal cross neutralizations were demonstrated when purified type F and E toxins were reacted with antitoxins which were obtained with immunizing toxoids prepared with purified toxins.

Citing Articles

Detection of botulinum neurotoxin serotype A, B, and F proteolytic activity in complex matrices with picomolar to femtomolar sensitivity.

Dunning F, Ruge D, Piazza T, Stanker L, Zeytin F, Tucker W Appl Environ Microbiol. 2012; 78(21):7687-97.

PMID: 22923410 PMC: 3485704. DOI: 10.1128/AEM.01664-12.


Mapping of the antibody-binding regions on the HN-domain (residues 449-859) of botulinum neurotoxin A with antitoxin antibodies from four host species. Full profile of the continuous antigenic regions of the H-chain of botulinum neurotoxin A.

Atassi M, Dolimbek B Protein J. 2004; 23(1):39-52.

PMID: 15115181 DOI: 10.1023/b:jopc.0000016257.91979.06.


Clostridium botulinum type C toxin: a sketch of the molecule.

Syuto B, Kubo S Mol Cell Biochem. 1982; 48(1):25-32.

PMID: 6817077 DOI: 10.1007/BF00214819.


Clostridium botulinum neurotoxin.

Sugiyama H Microbiol Rev. 1980; 44(3):419-48.

PMID: 6252433 PMC: 373187. DOI: 10.1128/mr.44.3.419-448.1980.


Evaluation of neutralizing antibodies to type A, B, E, and F botulinum toxins in sera from human recipients of botulinum pentavalent (ABCDE) toxoid.

Siegel L J Clin Microbiol. 1989; 27(8):1906-8.

PMID: 2768475 PMC: 267699. DOI: 10.1128/jcm.27.8.1906-1908.1989.


References
1.
Sugiyama H, Dasgupta B, Yang K . Toxicity of purified botulinal toxin fed to mice. Proc Soc Exp Biol Med. 1974; 147(2):589-91. DOI: 10.3181/00379727-147-38394. View

2.
Sugiyama H, Oishi I, Dasgupta B . Evaluation of type A botulinal toxin assays that use antitoxin to crystalline toxin. Appl Microbiol. 1974; 27(2):333-6. PMC: 380030. DOI: 10.1128/am.27.2.333-336.1974. View

3.
Dasgupta B, BOROFF D, Cheong K . Isolation of chromatographically pure toxin of Clostridium botulinum type B. Biochem Biophys Res Commun. 1968; 32(6):1057-63. DOI: 10.1016/0006-291x(68)90137-x. View

4.
Knox J, Brown W, Spero L . The role of sulfhydryl groups in the activity of type A botulinum toxin. Biochim Biophys Acta. 1970; 214(2):350-4. DOI: 10.1016/0005-2795(70)90012-7. View

5.
Dasgupta B, BERRY L, BOROFF D . Purification of Clostridium botulinum type A toxin. Biochim Biophys Acta. 1970; 214(2):343-9. DOI: 10.1016/0005-2795(70)90011-5. View